Compile Data Set for Download or QSAR
Report error Found 6 Enz. Inhib. hit(s) with all data for entry = 5917
TargetC-X-C chemokine receptor type 2(Human)
Sanofi

US Patent
LigandPNGBDBM100343(US8501981, 52)
Affinity DataIC50: 920nMAssay Description:CXCR2 inhibition using calcium fluorescence assay (FLIPR).More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/30/2013
Entry Details
Go to US Patent

TargetC-X-C chemokine receptor type 2(Human)
Sanofi

US Patent
LigandPNGBDBM100345(US8501981, 73)
Affinity DataIC50: 1.25E+3nMAssay Description:CXCR2 inhibition using calcium fluorescence assay (FLIPR).More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/30/2013
Entry Details
Go to US Patent

TargetC-X-C chemokine receptor type 2(Human)
Sanofi

US Patent
LigandPNGBDBM100347(US8501981, 166)
Affinity DataIC50: 1.67E+3nMAssay Description:CXCR2 inhibition using calcium fluorescence assay (FLIPR).More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/30/2013
Entry Details
Go to US Patent

TargetC-X-C chemokine receptor type 2(Human)
Sanofi

US Patent
LigandPNGBDBM100342(US8501981, 46)
Affinity DataIC50: 1.76E+3nMAssay Description:CXCR2 inhibition using calcium fluorescence assay (FLIPR).More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/30/2013
Entry Details
Go to US Patent

TargetC-X-C chemokine receptor type 2(Human)
Sanofi

US Patent
LigandPNGBDBM100344(US8501981, 55)
Affinity DataIC50: 2.56E+3nMAssay Description:CXCR2 inhibition using calcium fluorescence assay (FLIPR).More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/30/2013
Entry Details
Go to US Patent

TargetC-X-C chemokine receptor type 2(Human)
Sanofi

US Patent
LigandPNGBDBM100346(US8501981, 105)
Affinity DataIC50: 3.23E+3nMAssay Description:CXCR2 inhibition using calcium fluorescence assay (FLIPR).More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/30/2013
Entry Details
Go to US Patent